Description

The chemistry of azides is a speedily developing research area. The results in azides investigation are important for the creation of new fluorescent tags, bioconjugative techniques, new synthetic methodologies and new compounds with promising biological properties.
Firstly, organic azides are important building blocks for the synthesis of triazoles by Cu-catalyzed azide-alkyne cycloaddition (CuAAC), [1,2] strain-promoted azide-alkyne cycloaddition (SPAAC) [3-4] and organocatalytic interaction with carbonyl compounds [5]. However other types of synthetic transformations such as reduction to amines, Staudinger reaction and nitrene generation followed by different transformations of these highly reactive species should not be forgotten. [6,7] The unique role of azide chemistry is illustrated by applicability of all reaction mentioned above for biosystems that is caused by the bioorthogonality of azide functional group. Following this way, the chemistry of azides is employed in bioconjugation using CuAAC, SPAAC, Staudinger ligation and photoaffinity labeling. [8]
An important area of azides application is using them as fluorogenic probes – molecules, which being bonded to the target, change one of their fluorescence parameters [9]. It should be noted that both the target and the fluorophore must have functional groups which are able to react with each other under mild conditions. During last decade, azido-substituted heterocycles have been broadly studied in this direction. Organic azides can act as fluorogenic labels due to their ability to react with alkynes through 1,3-dipolar cycloaddition affording 1,2,3-triazoles with dissimilar fluorescent properties [10, 11]. Besides, the novel approach to obtain new specific bioactive compound based on 1,2,3-triazoles are able to link promising heterocyclic molecule with natural product. The hybrids may be more active than their parent compounds and be able to overcome drug resistance [12].
In the previous research of Prof. Tsogoeva group, artemisinin-based hybrids were investigated [13-15] in particular artemisinin–(iso)quinolone hybrids [16]. According to our previous research of 4-azidocinnolines [17], we suggested that artemisinin–cinnoline hybrids are promising compounds due to similarity of heterocyclic core. Taking into account that the cinnoline core can be found both in biologically active compound [18-19], the development of a synthetic route towards azidocinnolines its artemisinin hybrids could lead to new biologically active molecules with remarkable properties.

Key findings for the project

In continuation of our research an efficient approach towards synthesis of 4-azido-6-halogencinnolines (Scheme 1) was developed with the aim of exploring photophysical and photochemical properties of their click reaction. This five-step synthesis of 4-azido-6-halogencinnolines (5a-c) is based on the Richter cyclization (iv) of 4-hepthinyltriazenes (3a-c) which forms 4-bromo-6-halogencinnolines (4a-c) and subsequent nucleophilic substitution of the bromine atom in 4th position cinnoline’s cycle to azide group. It was shown that the regioselectivity of substitution (v) was realized only if X is Cl or Br. In case of 4-bromine-6-fluorocynnoline (4a) it was not possible to carry out the substitution chemiselectively – the product of double displacement (6) was predominantly formed. All azides were converted to corresponding triazoles for future studying of their photophysical and photochemical properties as well as cytotoxity.
Azidocinnolines synthetized were found to be reactive in CuAAC and enol-mediated cycloaddition. Besides, we can specify that the organocatalytic method of carrying out the cycloaddition reaction is suitable for the synthesis of artemisinin hybrids.
The 4-azidocinnoline / cinnoline-4-amine pair is promising for the search for new fluorogenic / fluorochrome dyes, while in the azide / triazole pair the fluorescence is quenched due to photoinduced electron transfer and non-planar geometry.
AcronymGRISC_2019
StatusFinished
Effective start/end date2/11/195/12/19

ID: 49831222